Source:http://linkedlifedata.com/resource/pubmed/id/10973316
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2000-10-6
|
pubmed:abstractText |
Bone formation by osteoblasts is essential for skeletal growth and remodeling. Fra-1 is a c-Fos-related protein belonging to the AP-1 family of transcription factors. Here we show that transgenic mice overexpressing Fra-1 in various organs develop a progressive increase in bone mass leading to osteosclerosis of the entire skeleton, which is due to a cell-autonomous increase in the number of mature osteoblasts. Moreover, osteoblast differentiation, but not proliferation, was enhanced and osteoclastogenesis was also elevated in vitro. These data indicate that, unlike c-Fos, which causes osteosarcomas, Fra-1 specifically enhances bone formation, which may be exploited to stimulate bone formation in pathological conditions.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1078-8956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
980-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10973316-Animals,
pubmed-meshheading:10973316-Calcinosis,
pubmed-meshheading:10973316-Cell Differentiation,
pubmed-meshheading:10973316-Mice,
pubmed-meshheading:10973316-Mice, Transgenic,
pubmed-meshheading:10973316-Osteoblasts,
pubmed-meshheading:10973316-Osteosclerosis,
pubmed-meshheading:10973316-Phenotype,
pubmed-meshheading:10973316-Proto-Oncogene Proteins c-fos
|
pubmed:year |
2000
|
pubmed:articleTitle |
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1.
|
pubmed:affiliation |
Research Institute of Molecular Pathology (I.M.P.), Dr. Bohr-Gasse 7, A-1030 Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|